Procurement Biopsies in the Evaluation of Deceased Donor Kidneys

Copyright © 2018 by the American Society of Nephrology..

BACKGROUND AND OBJECTIVES: Biopsies taken at deceased donor kidney procurement continue to be cited as a leading reason for discard; however, the reproducibility and prognostic capability of these biopsies are controversial.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We compiled a retrospective, single-institution, continuous cohort of deceased donor kidney transplants performed from 2006 to 2009. Procurement biopsy information-percentage of glomerulosclerosis, interstitial fibrosis/tubular atrophy, and vascular disease-was obtained from the national transplant database. Using univariable, multivariable, and time-to-event analyses for death-censored graft survival, we compared procurement frozen section biopsy reports with reperfusion paraffin-embedded biopsies read by trained kidney pathologists (n=270). We also examined agreement for sequential procurement biopsies performed on the same kidney (n=116 kidneys).

RESULTS: For kidneys on which more than one procurement biopsy was performed (n=116), category agreement was found in only 64% of cases (κ=0.14). For all kidneys (n=270), correlation between procurement and reperfusion biopsies was poor: overall, biopsies were classified into the same category (optimal versus suboptimal) in only 64% of cases (κ=0.25). This discrepancy was most pronounced when categorizing percentage of glomerulosclerosis, which had 63% agreement (κ=0.15). Interstitial fibrosis/tubular atrophy and vascular disease had agreement rates of 82% (κ=0.13) and 80% (κ=0.15), respectively. Ninety-eight (36%) recipients died, and 56 (21%) allografts failed by the end of follow-up. Reperfusion biopsies were more prognostic than procurement biopsies (hazard ratio for graft failure, 2.02; 95% confidence interval, 1.09 to 3.74 versus hazard ratio for graft failure, 1.30; 95% confidence interval, 0.61 to 2.76), with procurement biopsies not significantly associated with graft failure.

CONCLUSIONS: We found that procurement biopsies are poorly reproducible, do not correlate well with paraffin-embedded reperfusion biopsies, and are not significantly associated with transplant outcomes.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Clinical journal of the American Society of Nephrology : CJASN - 13(2018), 12 vom: 07. Dez., Seite 1876-1885

Sprache:

Englisch

Beteiligte Personen:

Carpenter, Dustin [VerfasserIn]
Husain, S Ali [VerfasserIn]
Brennan, Corey [VerfasserIn]
Batal, Ibrahim [VerfasserIn]
Hall, Isaac E [VerfasserIn]
Santoriello, Dominick [VerfasserIn]
Rosen, Raphael [VerfasserIn]
Crew, R John [VerfasserIn]
Campenot, Eric [VerfasserIn]
Dube, Geoffrey K [VerfasserIn]
Radhakrishnan, Jai [VerfasserIn]
Stokes, M Barry [VerfasserIn]
Sandoval, P Rodrigo [VerfasserIn]
D'Agati, Vivette [VerfasserIn]
Cohen, David J [VerfasserIn]
Ratner, Lloyd E [VerfasserIn]
Markowitz, Glen [VerfasserIn]
Mohan, Sumit [VerfasserIn]

Links:

Volltext

Themen:

Allografts
Atrophy
Biopsy
Follow-Up Studies
Frozen Sections
Graft Survival
Journal Article
Kidney
Kidney Diseases
Kidney biopsy
Kidney transplantation
Paraffin Embedding
Pathologists
Prognosis
Reproducibility of Results
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Retrospective Studies
Tissue Donors
Transplant pathology
Transplantation
Vascular Diseases

Anmerkungen:

Date Completed 11.12.2019

Date Revised 13.08.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.2215/CJN.04150418

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM289954576